ArticleBioactive materials2026
Commensal microbiota-coated biohybrid implants induce antibiofilm, osteogenic, and immunomodulatory responses in a human 3D immunocompetent model.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical devices have revolutionized patient care; however, their abiotic surfaces remain highly susceptible to bacterial biofilm formation, enabling immune evasion and antibiotic resistance. Although antibacterial coatings can mitigate bacterial colonization, many rely on antimicrobial agents that may drive resistance and often lack the capacity to actively modulate host immunity or promote osteogenesis. Here, we introduce innovative Commensal Hybrid Materials (CHMs), multifunctional implant interfaces generated by coating titanium with commensal microflora via a heat-anchoring inactivation process to create a safe, stable surface layer. Surface analyses (SEM/EDS, FTIR, Raman, XPS) confirmed a thick, near-hydrophobic coating with a polar biomolecular overlayer bearing protein (amide), lipid (C-H), and phosphate/phosphoryl signatures. CHMs were non-haemolytic, biocompatible with human cells, enhanced macrophage antimicrobial activity by increasing reactive oxygen species production while maintaining balanced phagocytosis, and reduced biofilm formation by the periodontal pathogen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.